Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00785629 · ClinicalTrials.gov registry record · NA
A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD
A NA study, sponsored by Denver Nephrologists, P.C..
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT00785629: Completed NA study, sponsored by Denver Nephrologists, P.C..
NCT00785629 is a NA study that has completed, run by Denver Nephrologists, P.C.. The registered enrollment target is 148 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00785629, a NA study, has completed, sponsored by Denver Nephrologists, P.C..
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
Primary Outcome
mean serum phosphorus from months 3-9
Interventions
- DRUG Placebo
- DRUG Sevelamer Carbonate
- DRUG Lanthanum Carbonate
- DRUG Calcium acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-07 |
| Phase | NA |
What the finished NCT00785629 record still lists
NCT00785629 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00785629 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00785629 about?
NCT00785629 is a clinical study titled "A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD". The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease.
What is the current status of trial NCT00785629?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2009-02. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00785629?
The interventions under investigation include: Placebo (DRUG), Sevelamer Carbonate (DRUG), Lanthanum Carbonate (DRUG), Calcium acetate (DRUG).
Who is sponsoring clinical trial NCT00785629?
This trial is sponsored by Denver Nephrologists, P.C., which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00785629's enrollment target sits among peer trials
148 702nd of 2000 higher than 1,298 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia